HiFiBiO Therapeutics
Privately held: no public share price
Assets
(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 1 | TNFR2 (agonist)Monoclonal antibody | Non-Small Cell Lung Cancer | |
| Phase 1 | BTLAMonoclonal antibody | Non-Small Cell Lung Cancer |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.